US equities |
MU $989.04 ▲+0.00% SNDK $1,487.33 ▲+0.00% SKHY $162.23 ▲+0.00% NVDA $226.32 ▲+0.00% INTC $101.35 ▲+0.00% AMD $594.24 ▲+0.00% SPCX $163.42 ▲+0.00% META $742.96 ▲+0.00%
FinancialContent

Latest News about Steven D/ Reich

Recent news which mentions Steven D/ Reich

Artelo Enters Next Phase Of Evaluation Of Its Cannabinoid Receptor Targeting Drug For The Treatment Of Cancer-Related Anorexia And Weight Loss
Tickers ARTL AZN
Tags AZN Benzinga ARTL
From Benzinga